CD19-immunoPET for noninvasive visualization of CD19 expression in B-cell lymphoma patients

Abstract Cell- and antibody-based CD19-directed therapies have demonstrated great potential for treating B-cell non-Hodgkin lymphoma (B-NHL). However, all these approaches suffer from limited response rates and considerable toxicity. Until now, therapy decisions have been routinely based on histopat...

Full description

Bibliographic Details
Published in:	Biomarker Research
Main Authors:	Dominik Sonanini, Johannes Schwenck, Simone Blaess, Julia Schmitt, Andreas Maurer, Walter Ehrlichmann, Malte Ritter, Julia Skokowa, Manfred Kneilling, Gundram Jung, Falko Fend, Simon Krost, Christian M. Seitz, Peter Lang, Gerald Reischl, Rupert Handgretinger, Christian la Fougère, Bernd J. Pichler
Format:	Article
Language:	English
Published:	BMC 2024-05-01
Subjects:	CD19 Positron emission tomography Imaging biomarker Theranostics CAR-T cells Molecular imaging
Online Access:	https://doi.org/10.1186/s40364-024-00595-9

Similar Items

Advances and challenges in immunoPET methodology
by: Philipp Mohr, et al.
Published: (2024-02-01)

ImmunoPET: Antibody-Based PET Imaging in Solid Tumors
by: Reyhaneh Manafi-Farid, et al.
Published: (2022-06-01)

Ultra-low dose immunoPET using 64Cu-rituximab tracer for a human CD20 mouse model
by: Frezghi Habte, et al.
Published: (2025-04-01)

Making the effect visible – OX40 targeting nanobodies for in vivo imaging of activated T cells
by: Desiree I. Frecot, et al.
Published: (2024-10-01)

Interferon gamma immunoPET imaging to evaluate response to immune checkpoint inhibitors
by: Justin B. Hackett, et al.
Published: (2023-12-01)

Development of a toxin-selective immunotracer for in vivo detection of Clostridioides difficile infection by immunoPET
by: Mario González-Arjona, et al.
Published: (2025-06-01)

Advances in immunoPET/SPECT imaging: The role of Fab and F(ab′)2 fragments in theranostics
by: Wenpeng Huang, et al.
Published: (2025-08-01)

γδ T cell-mediated antibody-dependent cellular cytotoxicity with CD19 antibodies assessed by an impedance-based label-free real-time cytotoxicity assay
by: Ursula Jördis Eva Seidel, et al.
Published: (2014-12-01)

Radiochemistry, Production Processes, Labeling Methods, and ImmunoPET Imaging Pharmaceuticals of Iodine-124
by: Krishan Kumar, et al.
Published: (2021-01-01)

ImmunoPET imaging of TIGIT in the glioma microenvironment
by: Sarah R. Vincze, et al.
Published: (2024-03-01)

2-Nitroimidazole-Furanoside Derivatives for Hypoxia Imaging—Investigation of Nucleoside Transporter Interaction, <sup>18</sup>F-Labeling and Preclinical PET Imaging
by: Florian C. Maier, et al.
Published: (2019-02-01)

ImmunoPET provides a novel way to visualize the CD103+ tissue-resident memory T cell to predict the response of immune checkpoint inhibitors
by: Xiaoyu Fan, et al.
Published: (2024-01-01)

ImmunoPET imaging of Trop2 in patients with solid tumours
by: Wei Huang, et al.
Published: (2024-04-01)

725 Preliminary results of a prospective pilot study using CD8 ImmunoPET imaging to evaluate the immune response to radiation therapy (ELIXR)
by: Anna Wu, et al.
Published: (2023-11-01)

89 Non-invasive imaging of tumor-infiltrating B lymphocytes in a triple negative breast cancer model using anti-CD20 immunoPET
by: Sunidhi Jaiswal, et al.
Published: (2023-11-01)

Local and distant response to intratumoral immunotherapy assessed by immunoPET in mice
by: Aurélien Marabelle, et al.
Published: (2023-11-01)

Two birds with one stone: human SIRPα nanobodies for functional modulation and in vivo imaging of myeloid cells
by: Teresa R. Wagner, et al.
Published: (2023-12-01)

ImmunoPET Directed to the Brain: A New Tool for Preclinical and Clinical Neuroscience
by: Ángel García de Lucas, et al.
Published: (2023-01-01)

Targeting MT1-MMP as an ImmunoPET-Based Strategy for Imaging Gliomas.
by: A G de Lucas, et al.
Published: (2016-01-01)

Tissue Factor‐Targeted ImmunoPET Imaging and Radioimmunotherapy of Anaplastic Thyroid Cancer
by: Weijun Wei, et al.
Published: (2020-07-01)

Development of [89Zr]Zr-hCD103.Fab01A and [68Ga]Ga-hCD103.Fab01A for PET imaging to noninvasively assess cancer reactive T cell infiltration: Fab-based CD103 immunoPET
by: Xiaoyu Fan, et al.
Published: (2023-11-01)

Comparison of patient stratification by computed tomography radiomics and hypoxia positron emission tomography in head-and-neck cancer radiotherapy
by: Jairo A Socarrás Fernández, et al.
Published: (2020-07-01)

Application of immunoPET imaging to enhance head and neck squamous cell carcinoma clinical management
by: Waleed M. Almutairi, et al.
Published: (2025-10-01)

Zirconium 89 and Copper 64 for ImmunoPET: From Antibody Bioconjugation and Radiolabeling to Molecular Imaging
by: Laure Badier, et al.
Published: (2024-06-01)

169 immunoPETE: deciphering disease dynamics through comprehensive adaptive immune repertoire profiling
by: Dinesh Kumar, et al.
Published: (2023-11-01)

In vivo validation of the switch antibody concept: SPECT/CT imaging of the anti-CD137 switch antibody Sta-MB shows high uptake in tumors but low uptake in normal organs in human CD137 knock-in mice
by: Aya Sugyo, et al.
Published: (2022-09-01)

Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study
by: Birgit Federmann, et al.
Published: (2012-10-01)

PD-L1 has a heterogeneous and dynamic expression in gastric cancer with implications for immunoPET
by: Dina Ibrahim, et al.
Published: (2024-06-01)

Preliminary evidence of localizing CD8+ T-cell responses in COVID-19 patients with PET imaging
by: Hans J. P. M. Koenen, et al.
Published: (2024-05-01)

Lower proportion of CD19+IL-10+ and CD19+CD24+CD27+ but not CD1d+CD5+CD19+CD24+CD27+ IL-10+ B cells in children with autoimmune thyroid diseases
by: Karolina Stożek, et al.
Published: (2020-01-01)

Divergent Responses of Hydrophilic CdSe and CdSe@CdS Core–Shell Nanocrystals in Apoptosis and In Vitro Cancer Cell Imaging: A Comparative Analysis
by: Kishan Das, et al.
Published: (2023-09-01)

Concepts for agonistic targeting of CD40 in immuno-oncology
by: David M. Richards, et al.
Published: (2020-02-01)

T-Cell Depleted Haploidentical Transplantation in Children With Hematological Malignancies: A Comparison Between CD3+/CD19+ and TCRαβ+/CD19+ Depletion Platforms
by: Marta Gonzalez-Vicent, et al.
Published: (2022-06-01)

Whole-body visualization of SARS-CoV-2 biodistribution in vivo by immunoPET imaging in non-human primates
by: Alexandra Detrille, et al.
Published: (2025-03-01)

<sup>89</sup>Zr-Labeled AR20.5: A MUC1-Targeting ImmunoPET Probe
by: Kimberly Fung, et al.
Published: (2020-05-01)

Targeting CD276 for T cell-based immunotherapy of breast cancer
by: Ilona Hagelstein, et al.
Published: (2024-10-01)

Correction: T-cell depleted haploidentical transplantation in children with hematological malignancies: a comparison between CD3+/CD19+ and TCRαβ+/CD19+ depletion platforms
by: Marta Gonzalez-Vicent, et al.
Published: (2025-09-01)

294 Comparison of preclinical efficacy between CD19 CAR-T and CD3×CD19 bispecific antibody (blinatumomab)
by: Jun Huang, et al.
Published: (2023-11-01)

Helminth antigens differentially modulate the activation of CD4+ and CD8+ T lymphocytes of convalescent COVID-19 patients in vitro
by: Tomabu Adjobimey, et al.
Published: (2022-06-01)

ImmunoPET imaging of amyloid-beta in a rat model of Alzheimer’s disease with a bispecific, brain-penetrating fusion protein
by: Gillian Bonvicini, et al.
Published: (2022-12-01)